Company Filing History:
4 out of 88 
2 out of 168 
1 out of 4,948 
Years Active: 2010-2012
Title: Corinna Löhning: Innovator in Antibody Research
Introduction
Corinna Löhning is a prominent inventor based in Stockdorf, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 4 patents to her name, her work focuses on innovative solutions for medical applications.
Latest Patents
Löhning's latest patents include groundbreaking inventions related to nucleic acid molecules encoding anti-amyloid beta antibodies. These inventions involve antibody molecules that specifically recognize two regions of the β-A4 peptide. The first region comprises the amino acid sequence AEFRHDSGY, while the second region includes the sequence VHHQKLVFFAEDVG. Additionally, her patents disclose nucleic acid molecules encoding these antibody molecules, as well as vectors and hosts that incorporate them. The inventions also provide compositions, preferably pharmaceutical or diagnostic, that utilize these compounds for specific applications.
Career Highlights
Throughout her career, Corinna Löhning has worked with notable companies such as Morphosys AG and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.
Collaborations
Löhning has collaborated with esteemed colleagues, including Michael Otto Bardroff and Bernd Bohrmann. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Corinna Löhning's work in antibody research exemplifies the innovative spirit of modern biotechnology. Her contributions continue to pave the way for advancements in medical treatments and diagnostics.